Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease.
Roblin, Xavier, Gérard Duru, Konstantinos Papamichael, Adam S Cheifetz, Sandy Kwiatek, Anne-Emmanuelle Berger, Mathilde Barrau, Louis Waeckel, Stéphane Nancey, and Stephane Paul. 2023. “Development of Antibodies to Ustekinumab Is Associated With Loss of Response in Patients With Inflammatory Bowel Disease.”. Journal of Clinical Medicine 12 (10).